Landec(US:LFCR) Globenewswireยท2025-07-31 20:05Company Overview - Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [3] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories [3] Upcoming Financial Results - Lifecore will report its financial results for the fourth quarter and fiscal year 2025 on August 7, 2025, after market close [1] - A webcast hosted by Lifecore's senior management team will take place at 4:30 p.m. Eastern Time on the same day to discuss the results [1][2] Webcast Access - Investors can listen to the live webcast or access the archived version on Lifecore's Investor Events & Presentations page [2] - The archived version will be available for 30 days following the live event [2] Contact Information - Lifecore's investor relations contact is Stephanie Diaz from Vida Strategic Partners, reachable at 415-675-7401 [4] - Media inquiries can be directed to Tim Brons at 415-675-7402 [4] - Ryan D. Lake serves as the CFO of Lifecore Biomedical and can be contacted at 952-368-6244 [4]